Our numerous international contacts have enabled
us, since the beginning of the health crisis, to
provide regions and distributors with the personal
protection and antigen tests that are essential in the
fight against Covid-19.
Covid -19
Personal Protection
Antigen Tests
The Company
With more than 10 years of experience of its
team and partners, BIO AMOVIR focuses its
research on a new concept of treatment of
diseases caused by enveloped viruses such as
AIDS, influenza, herpes, Covid-19.
Research
Viral Disease
The Company
Created in 2015, BIO AMOVIR is an R&D, Marketing , distribution and creative company specialised in the field of Virology.Our commitments
BIO AMOVIR health products have a quality level that ensures the safety of patients and the environment.Corporate
BIO AMOVIR is owned by the SAMFI-INVEST SAS Group, Alain Samson's family holding company, based in Caen, Normandy.
Based on the first research results, an
innovative technology has been developed.
AMOVIR® Technology, through its barrier
action and the stimulation of the immune
system, prevents herpes from the very first
signs.
Herpes & Cold sores
Medical Device
BIO AMOVIR SAS
179 rue du Poirier
14650 CARPIQUET contact: contact@bioamovir.com
FRANCE
©2020 par BIO AMOVIR SAS.
Innovating
tomorrow's
health product
Our numerous international contacts have enabled us, since the
beginning of the health crisis, to provide regions and distributors
with the personal protection and antigen tests that are essential
in the fight against Covid-19.
Covid -19
Personal Protection
Antigen Tests
The Company
With more than 10 years of experience of its team and partners, BIO
AMOVIR focuses its research on a new concept of treatment of
diseases caused by enveloped viruses such as AIDS, influenza,
herpes, Covid-19.
Research
Viral Disease
The Company
Created in 2015, BIO AMOVIR is an R&D, Marketing , distribution and creative company specialised in the field of Virology.Our commitments
BIO AMOVIR health products have a quality level that ensures the safety of patients and the environment.Corporate
BIO AMOVIR is owned by the SAMFI-INVEST SAS Group, Alain Samson's family holding company, based in Caen, Normandy.
Based on the first research results, an innovative technology has
been developed. AMOVIR® Technology, through its barrier
action and the stimulation of the immune system, prevents
herpes from the very first signs.
Herpes & Cold sores
Medical Device
BIO AMOVIR SAS
179 rue du Poirier
14650 CARPIQUET
FRANCE contact: contact@bioamovir.com
©2020 par BIO AMOVIR SAS.
Innovating
tomorrow's
health product
